Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery episode artwork

EPISODE · Oct 14, 2017 · 26 MIN

Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery

from The AI in Business Podcast

In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery. For more in-depth interviews on the business applications of artificial intelligence, find us online at: www.TechEmergence.com

NOW PLAYING

Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery

0:00 26:36

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The AI in Business Podcast?

This episode is 26 minutes long.

When was this The AI in Business Podcast episode published?

This episode was published on October 14, 2017.

What is this episode about?

In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in...

Can I download this The AI in Business Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!